KYIV, UKRAINE. April 21, 2021. FARMAK JSC, leader of the Ukrainian pharmaceutical market and the country’s largest exporter of medicinal products since 2010, reiterates its support for Mexico’s government decision to create an international tender process through the United Nations Office for Project Services, UNOPS, to acquire several products of key significance for the Mexican pharmaceutical market and the health of the Mexican people.
FARMAK JSC has participated in the delivery of an important life-saving product, Propofol with EDTA under ITB/2020/17938 (“clave 010.000.0246.00”). This is the most widely used intravenous anesthetic, one with a number of advantages over the same product without edetate disodium dihydrate, EDTA. As a result, Farmak JSC is eagerly awaiting UNOPS decision on this process. Such decision was originally scheduled to take place in March 2021 to begin supplying the product in May, without there being now certainty as of the new date for UNOPS decision.
“We are ready to provide 1,336,138 units of Propofol WITH EDTA as soon as the tender is defined by UNOPS and, as we expect, we are deemed the best offer under the code on which we are participating”, said Viktor Kostiuk Business Development Director of JSC “Farmak”.
“I want to stress the fact that under code / clave 0246, it is clear that UNOPS is requesting Propofol with ETDA, as opposed to other codes / claves where the tender does not require the presence of such a key component of the anesthetic as EDTA. For that, we are certain that UNOPS will only consider tenders that align strictly to the requirements made”, – Mr. Victor continued.
FARMAK JSC will continue to monitor closely the progress made by UNOPS on the matter at hand. Its trust is placed on a key international organization such as UNOPS, which is being trusted in turn by the Mexican government to carry out a most important international tender process.
USD 500,000 to be provided by the Company will be used for the development of KSE (Kyiv School of Economics) to improve education in Ukraine. The pharmaceutical company Farmak will provide KSE with monetary funds to equip the training rooms and areas of the new campus, as well as to develop existing and launch new majors, […]
The Shostka Children’s Hospital that has made available inpatient treatment of children diagnosed with COVID-19 since April 2021 has been provided with medical and diagnostic equipment purchased by the Zhebrivski Family Charitable Foundation. The operating COVID-19 treatment unit at the Shostka Hospital will make it possible to provide the qualitative ...
Farmak as a leader of the Ukrainian pharmaceutical market* has been included in the rating of TOP 200 largest Ukrainian companies in terms of tax payments for 2020 and has become the only representative of the pharmaceutical industry in this rating. At year-end 2020, the Company transferred UAH 712.1 million of taxes and fees to […]